UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 1972
Journal
2005, ISBN 9780299203948, xii, 341
Book
Frontiers in microbiology, ISSN 1664-302X, 09/2018, Volume 9, pp. 2271 - 2271
Non-tuberculous mycobacteria | Antimycobacterials | Mouse models | Pulmonary infection | M. kansasii | Life Sciences & Biomedicine | Microbiology | Science & Technology | Drug resistance in microorganisms | Mycobacterial infections | Dosage and administration | Research | Drug therapy | Rifampin | Isoniazid | mouse models | non-tuberculous mycobacteria | pulmonary infection | antimycobacterials
Journal Article
Chest, ISSN 0012-3692, 12/2020
Journal Article
International journal of nanomedicine, ISSN 1176-9114, 2020, Volume 15, pp. 2231 - 2258
Nanoparticles | Granuloma | Mycobacterium | Tuberculosis | Antimycobacterial | Macrophage | Pharmacology & Pharmacy | Science & Technology - Other Topics | Nanoscience & Nanotechnology | Life Sciences & Biomedicine | Science & Technology | Proteins | Silver | Dendritic cells | Disease | Antibiotics | Pathogenesis | Mortality | Bacteria | Infections | Drug resistance | Index Medicus | antimycobacterial | macrophage | mycobacterium | nanoparticles | tuberculosis | granuloma
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 07/2019, Volume 24, Issue 13, p. 2449
Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Microbial Sensitivity Tests | Animals | Humans | Phenols - therapeutic use | Tuberculosis - drug therapy | Antitubercular Agents - pharmacology | Drug Discovery | Mycobacterium tuberculosis - drug effects | Antitubercular Agents - therapeutic use | Phenols - pharmacology | Index Medicus | antimycobacterial | natural products | tuberculosis drugs | phytochemicals | phenolic
Journal Article
Pharmaceutical research, ISSN 0724-8741, 7/2018, Volume 35, Issue 7, pp. 1 - 11
Biochemistry, general | Biomedical Engineering | inhaled dosage forms | Biomedicine | tuberculosis treatment | Pharmacy | Medical Law | iron metal-organic framework (MOF) | MRI contrast agent | theranostic system | Pharmacology/Toxicology | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Cell Line | Iron - administration & dosage | Drug Carriers - metabolism | Antitubercular Agents - chemistry | Magnetic Resonance Spectroscopy - methods | Iron - chemistry | Drug Carriers - administration & dosage | Iron - metabolism | Drug Carriers - chemistry | Dose-Response Relationship, Drug | Animals | Theranostic Nanomedicine - methods | Fibroblasts - drug effects | Tuberculosis - drug therapy | Antitubercular Agents - administration & dosage | Antitubercular Agents - metabolism | Tuberculosis - metabolism | Fibroblasts - metabolism | Drugs | Drug delivery systems | Tuberculosis | Antitubercular agents | Respiratory agents | Contrast media | Vehicles | Scanning electron microscopy | Particle size | Nuclear magnetic resonance--NMR | Toxicity | X ray powder diffraction | Metals | Cytotoxicity | Iron | Drug delivery | Dissolution | Contrast agents | Spectrometry | Diffraction | Magnetic resonance imaging | Lungs | Fibroblasts | Resonance | Safety | Antimycobacterial agents | Metal-organic frameworks | Isoniazid | Index Medicus | Research Paper
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 06/2019, Volume 20, Issue 12, p. 2868
Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Bacterial Proteins - antagonists & inhibitors | Humans | Antitubercular Agents - pharmacology | Bacterial Proteins - genetics | Host-Pathogen Interactions - drug effects | Molecular Targeted Therapy | Mycobacterium tuberculosis - drug effects | Oxidative Phosphorylation - drug effects | Animals | Tuberculosis, Multidrug-Resistant - microbiology | Oxidation-Reduction - drug effects | Biomarkers | Bacterial Proteins - metabolism | Drug Resistance, Bacterial - drug effects | Mycobacterium tuberculosis - metabolism | Mycobacterium tuberculosis - genetics | Precision Medicine | Efflux | Reductases | Therapy | Active transport | Salts | Streptomycin | Cell walls | Biosynthesis | Arabinogalactan | Drug resistance | Detergents | Fatty acids | Heavy metals | Bile salts | Membrane proteins | Proteins | Tuberculosis | Pentose | Public health | Reductase | Index Medicus | antimycobacterial | host-directed therapy | drug resistance | Mycobacterium tuberculosis | novel targets | non-lethal targets
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 12/2018, Volume 79, Issue 4, pp. 474 - 480
Antiretroviral drugs | Medical research | Therapy | Medical treatment | Mortality | Clinical trials | Genomes | Single-nucleotide polymorphism | Drug resistance | Patients | Antiretroviral therapy | Gene sequencing | Tuberculosis | Antiretroviral agents | Human immunodeficiency virus--HIV | Sputum | Antimycobacterial agents | Polymorphism | Index Medicus | AIDS/HIV
Journal Article
International journal of antimicrobial agents, ISSN 0924-8579, 1991
Journal